rs150430628
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP3BP6BS1BS2
The NM_000252.3(MTM1):āc.1052A>Gā(p.Lys351Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000392 in 1,192,902 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 152 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000252.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTM1 | NM_000252.3 | c.1052A>G | p.Lys351Arg | missense_variant, splice_region_variant | 10/15 | ENST00000370396.7 | NP_000243.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000196 AC: 22AN: 112354Hom.: 0 Cov.: 24 AF XY: 0.000203 AC XY: 7AN XY: 34500
GnomAD3 exomes AF: 0.000199 AC: 35AN: 175656Hom.: 0 AF XY: 0.000163 AC XY: 10AN XY: 61422
GnomAD4 exome AF: 0.000413 AC: 446AN: 1080548Hom.: 0 Cov.: 27 AF XY: 0.000418 AC XY: 145AN XY: 347190
GnomAD4 genome AF: 0.000196 AC: 22AN: 112354Hom.: 0 Cov.: 24 AF XY: 0.000203 AC XY: 7AN XY: 34500
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 06, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 22, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 20, 2020 | - - |
Severe X-linked myotubular myopathy Benign:2
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 06, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.1052A>G (p.K351R) alteration is located in exon 10 (coding exon 9) of the MTM1 gene. This alteration results from a A to G substitution at nucleotide position 1052, causing the lysine (K) at amino acid position 351 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at